Comparison of Triple Antibiotic Paste With Combination of Chitosan and Calcium Hydroxide as a Root Canal Disinfectant
Clinical and Radiographic Comparative Evaluation of Healing of Periapical Lesion Using Triple Antibiotic Paste With Combination of Chitosan and Calcium Hydroxide When Used as a Root Canal Disinfectant- An In Vivo Study
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Aim: To evaluate and compare the healing of periapical lesions using chitosan mixed with calcium hydroxide or Triple Antibiotic Paste at 3,6 and 12 months.
Methodology:
20 adult patients having periapical lesions in single rooted teeth were selected in this study after being assessed using the PAI index. Patients were randomly assigned to: Group - I (n=10) Chitosan with Ca (OH)2 and Group -II (n=10) Triple Antibiotic paste (TAP)
After access opening and cleaning and shaping were done in the first visit, the pertinent intracanal medicaments were placed depending on the patient group. After 4 weeks, on the second visit, the medicament was removed andobturation was done in the asymptomatic teeth. Both clinical and radiographic endodontic evaluation was done at 0, 3, 6 and 12months using the same parameters.
Radiographic evaluation was done using the PAI Index and was compared at 0, 3, 6, and 12 months after treatment, Z Test.
Type d'étude
Inscription (Anticipé)
Phase
- Phase 2
- Phase 3
Contacts et emplacements
Lieux d'étude
-
-
Maharashtra
-
Pune, Maharashtra, Inde, 411 018
- Recrutement
- Dr DY Patil Dental College And Hospital (DPU)
-
Contact:
- Soumya S Shetty, MDS
- Numéro de téléphone: 8888200888
- E-mail: drsoumyasshetty@gmail.com
-
Contact:
- anita B Tandale, MDS
- Numéro de téléphone: 9850537432
- E-mail: anita.tandale@gmail.com
-
Chercheur principal:
- soumya S shetty, MDS
-
Sous-enquêteur:
- anita B tandale, MDS
-
Sous-enquêteur:
- piyush D oswal, MDS
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Patients aged between 18 and 40 years Periapical lesion (not more than 5mm) radiographically.on single rooted teeth
- Roots with closed apex.
- Systemically healthy patients.
Exclusion Criteria:All patients who respond positive to allergic patch test [triple antibiotic paste] and drugs.
- Teeth with previous endodontic therapy performed.
- Patients with a history of any systemic diseases.
- Pregnant and lactating women.
- Tooth associated with vertical root fracture and coronal perforation.
- Tooth affected with calcific degeneration.
- Presence of external or internal root resorption.
- Blunderbuss apex.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Chitosan calcium hyroxide paste
after the access preparation and cleaning and shaping, chitosan calcium hydroxide paste will be placed in the canal and kept for 4 weeks.
|
after the access preparation and cleaning and shaping was done in 1st appointment using k files,"Mani" and protapers,"Dentsply" then in, chitosan calcium hydroxide paste," or ciprofloxacin metronidazole minocycline paste placed in the canal and kept for 4 weeks.
Autres noms:
|
|
Comparateur actif: triple antibiotic paste
after the access preparation and cleaning and shaping, ciprofloxacin metronidazole minocycline paste will be :placed in the canal and kept for 4 weeks.
|
after the access preparation and cleaning and shaping was done in 1st appointment using k files,"Mani" and protapers,"Dentsply" then in, chitosan calcium hydroxide paste," or ciprofloxacin metronidazole minocycline paste placed in the canal and kept for 4 weeks.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
healing of periapical lesion
Délai: change in PAI index from baseline to 3 months, baseline to 6 months and baseline to 12 months
|
the periapical status will be assessed by using the periapical index [PAI] using radiographs and scoring was done according to following scoring index as
|
change in PAI index from baseline to 3 months, baseline to 6 months and baseline to 12 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
patient pain perception
Délai: 3months, 6months and 12 months
|
pain will be assessed using visual analogue (VAS )scale along with any swelling following scale of -10 with 0 score depicts no pain and score 10 depicts severe pain
|
3months, 6months and 12 months
|
Collaborateurs et enquêteurs
Les enquêteurs
- Directeur d'études: Piyush D Oswal, MDS, Dr. D Y Patil Dental College, Pimpri, Pune
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- DYPV/EC/55/16
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .